OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Aim
The aim of the workshop is to increase awareness of the programme, and encourage research funding applications to A-TAP, which has funds to help pump prime experimental medicine studies. Up to £100k per study will be awarded to Oxford and Birmingham based projects in 2019.
Morning / afternoon sessions
There is an option to attend either the morning session (10am-1pm) or the afternoon session (2pm-5pm). Lunch will be served for all delegates from 1pm-2pm.
Background to the A-TAP
The Kennedy Trust for Rheumatology Research has provided £7M to the Universities of Oxford and Birmingham to create the Arthritis-Therapy Acceleration Programme (A-TAP). The A-TAP is pioneering the development of new experimental medicine strategies using basket trial design and pathology based outcomes to provide early go-no-go decisions in immune mediated inflammatory diseases (including rheumatoid arthritis, Sjögren’s syndrome, spondyloarthropathy and inflammatory bowel disease).
The aim of the A-TAP is to move the field away from the traditional “organ-based, speciality- focussed” approach to experimental medicine to a process-driven, pathway-focussed classification for inflammatory diseases. The A-TAP will facilitate the development of novel treatments based on the underlying causes of inflammatory disease. We are working with industry partners to develop novel proof-of-concept and proof-of-mechanism trials to help us treat the cause of disease and not just their symptoms.
